Oxymatrine Inhibits Renal Cell Carcinoma Progression by Suppressing β-Catenin Expression
ConclusionsOur findings illuminate oxymatrine as an effective antitumor agent in renal cell carcinoma, and suggest it a promising therapeutic application in renal cell carcinoma treatment.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Drugs & Pharmacology | Kidney Cancer | Renal Cell Carcinoma | Study